Exosome-Based Therapy: As previously mentioned, utilizing normal chondrocyte-derived exosomes to deliver miR-195 effectively targets KIF4A in osteosarcoma cells, leading to inhibited growth and enhanced apoptosis [90]. The gene discussed is KIF4A; the disease is osteosarcoma.